Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Brain Research

• Publication date

  1992-12-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-8993(92)90855-4PMID 1362921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intrinsic neuronal determinants of regeneration.

  1992cited by this paper
• Stimulation of biosynthesis of nerve growth factor by acidic fibroblast growth factor in cultured mouse astrocytes.

  1991cited by this paper
• EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

  1991cited by this paper
• Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.

  1991cited by this paper
• Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats.

  1991cited by this paper
• Epidermal Growth Factor Enhances Striatal Dopaminergic Parameters in the 1‐Methyl‐4‐Phenyl‐l, 2, 3, 6‐Tetrahydropyridine‐Treated Mouse

  1991cited by this paper
• Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes.

  1991cited by this paper
• The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]

  1991cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes

  1991cited by this paper
• Local support cells promote survival of substantia nigra dopaminergic neurons in culture.

  1991cited by this paper
• Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family.

  1990cited by this paper
• Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain.

  1990cited by this paper
• Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

  1990cited by this paper
• Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II

  1990cited by this paper
• Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone.

  1990cited by this paper
• Toxicity of 1‐Methyl‐4‐Phenylpyridinium for Rat Dopaminergic Neurons in Culture: Selectivity and Irreversibility

  1990cited by this paper
• Glia protect hippocampal neurons against excitatory amino acid‐induced degeneration: Involvement of fibroblast growth factor

  1990cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture.

  1989cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture

  1989cited by this paper
• Effect of deprenyl on the progression of disability in early Parkinson's disease.

  1989cited by this paper
• Abnormalities of the electron transport chain in idiopathic parkinson's disease

  1989cited by this paper
• The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.

  1989cited by this paper
• Regulation of production by primary cultures of rat forebrain astrocytes of a trophic factor important for the development of cholinergic neurons.

  1989cited by this paper
• Rate of cell death in parkinsonism indicates active neuropathological process

  1988cited by this paper
• Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen.

  1988cited by this paper
• Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration.

  1988cited by this paper
• Selective Destruction of Cultured Dopaminergic Neurons from Fetal Rat Mesencephalon by 1‐Methyl‐4‐Phenylpyridinium: Cytochemical and Morphological Evidence

  1988cited by this paper
• Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons

  1988cited by this paper
• In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor.

  1988cited by this paper
• 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Metabolism and l‐Methyl‐4‐Phenylpyridinium Uptake in Dissociated Cell Cultures from the Embryonic Mesencephalon

  1988cited by this paper
• Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo

  1988cited by this paper
• Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro

  1988cited by this paper
• Studies on the Metabolism and Toxicity of l‐Methyl‐4‐Phenyl‐l,2,3,6‐Tetrahydropyridine in Cultures of Embryonic Rat Mesencephalon

  1988cited by this paper
• Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice.

  1988cited by this paper
• Neurotrophic effects of basic and acidic fibroblast growth factors are not mediated through glial cells.

  1988cited by this paper
• Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

  1987cited by this paper
• Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor.

  1987cited by this paper
• An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.

  1987cited by this paper
• Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

  1986cited by this paper
• Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.

  1986cited by this paper
• Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.

  1986cited by this paper
• Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

  1986cited by this paper
• Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey.

  1986cited by this paper
• ASTROGLIAL CELL CONTRIBUTIONS TO NEURONAL SURVIVAL AND NEURITIC GROWTH

  1986cited by this paper
• Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.

  1986cited by this paper
• 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.

  1986cited by this paper
• 1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture.

  1985cited by this paper
• Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the Mouse

  1985cited by this paper
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

  1985cited by this paper
• Purification of two astroglial growth factors from bovine brain

  1985cited by this paper
• The output of neuronotrophic and neurite-promoting agents from rat brain astroglial cells: a microculture method for screening potential regulatory molecules.

  1985cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon.

  1984cited by this paper
• Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

  1984cited by this paper
• Pargyline prevents MPTP-induced parkinsonism in primates.

  1984cited by this paper
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

  1984cited by this paper
• Injury-induced neuronotrophic activity in adult rat brain: correlation with survival of delayed implants in the wound cavity

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• A neurotrophic factor (NTF) released from primary glial cultures supports survival and fiber outgrowth of cultured hippocampal neurons

  1982cited by this paper
• Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system

  1982cited by this paper
• Extensive elongation of axons from rat brain into peripheral nerve grafts

  1982cited by this paper
• Mitogens for glial cells: a comparison of the response of cultured astrocytes, oligodendrocytes and Schwann cells.

  1981cited by this paper
• Stimulation of resistance to 6-hydroxydopamine in a human neuroblastoma cell line by nerve growth factor.

  1981cited by this paper
• Influences of the glial environment on the elongation of axons after injury: transplantation studies in adult rodents.

  1981cited by this paper
• Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures

  1981cited by this paper
• Trophic interactions between astroglial cells and hippocampal neurons in culture.

  1980cited by this paper
• Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions

  1980cited by this paper
• Growth of a rat neuroblastoma cell line in serum-free supplemented medium.

  1979cited by this paper
• Regrowth of severed axons in the neonatal central nervous system: establishment of normal connections.

  1979cited by this paper
• Regeneration of monoaminergic and cholinergic neurons in the mammalian central nervous system.

  1979cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview

  2020cites this paper
• Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.

  2020cites this paper
• Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture

  2019cites this paper
• Neurotropic growth factors and glycosaminoglycan based matrices to induce dopaminergic tissue formation.

  2015cites this paper
• Glial-Neuronal Interactions during Oxidative Stress Implications for Parkinson’s Disease

  2013cites this paper
• The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson's disease

  2012cites this paper
• Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

  2012cites this paper
• Pathways towards an effective immunotherapy for Parkinson’s disease

  2011cites this paper
• Pathways towards an effective immunotherapy for

  2011cites this paper
• ErbB receptor signaling in astrocytes: a mediator of neuron-glia communication in the mature central nervous system.

  2010cites this paper
• Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?

  2010cites this paper
• Differential cellular FGF-2 upregulation in the rat facial nucleus following axotomy, functional electrical stimulation and corticosterone: a possible therapeutic target to Bell's palsy

  2010cites this paper
• Ludwig Institute for Cancer Research and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden GENERATION OF DOPAMINE NEURONS IN VIVO AND FROM EMBRYONIC STEM CELLS IN VITRO

  2009cites this paper
• Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

  2009cites this paper
• Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.

  2009cites this paper
• Generation of dopamine neurons in vivo and from embryonic stem cells in vitro

  2009cites this paper
• Neurotrophic support of midbrain dopaminergic neurons.

  2009cites this paper
• GDNF therapy for Parkinson’s disease

  2008cites this paper
• Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.

  2008cites this paper
• Temporal changes in the expression of TGF-beta 1 and EGF in the ventral horn of the spinal cord and associated precentral gyrus in adult Rhesus monkeys subjected to cord hemisection.

  2008cites this paper
• Chapter XXIV – Parkinson's Disease

  2007cites this paper
• Aortic coarctation hypertension induces fibroblast growth factor-2 immunoreactivity in the stimulated nucleus tractus solitarii

  2007cites this paper
• Chapter III – Alzheimer's Disease

  2007cites this paper
• Neurotrophic factors and Parkinson's disease.

  2007cites this paper
• CHAPTER 8 – Gene Therapy for Parkinson's Disease

  2006cites this paper
• Adult rat bone marrow stromal cells express genes associated with dopamine neurons.

  2006cites this paper
• Fibroblast growth factor‐2 immunoreactivity is present in the central and peripheral auditory pathways of adult rats

  2005influential citation
• GLIAL bFGF AND S100 IMMUNOREACTIVITIES INCREASE IN ASCENDING DOPAMINE PATHWAYS FOLLOWING STRIATAL 6-OHDA-INDUCED PARTIAL LESION OF THE NIGROSTRIATAL SYSTEM: A STEROLOGICAL ANALYSIS

  2005cites this paper
• FGF‐2 and S100β immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6‐OHDA‐induced partial lesion of the nigrostriatal system

  2004cites this paper
• Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion

  2004cites this paper
• Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro

  2004cites this paper
• Conditioned Place Preference and Locomotor Sensitization after Repeated Administration of Cocaine or Methamphetamine in Rats Treated with Epidermal Growth Factor during the Neonatal Period

  2004cites this paper
• Gene therapy for Parkinson's disease

  2004cites this paper
• Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.

  2003cites this paper
• Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons.

  2003cites this paper
• Intranigral infusion of interleukin‐1β activates astrocytes and protects from subsequent 6‐hydroxydopamine neurotoxicity

  2003cites this paper
• Levodopa Is Toxic to Dopamine Neurons in an in Vitro but Not an in Vivo Model of Oxidative Stress

  2003cites this paper
• Regulation of α‐synuclein by bFGF in cultured ventral midbrain dopaminergic neurons

  2003influential citation
• Lipopolysaccharide prevents cell death caused by glutathione depletion: possible mechanisms of protection.

  2002cites this paper
• Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.

  2002cites this paper
• Glutathione depletion and oxidative stress.

  2002cites this paper
• Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP‐treated monkeys: Feasibility relevant to multiple‐target grafting as a therapy for Parkinson's disease

  2002cites this paper
• Glial-Neuronal Interactions during Oxidative Stress

  2002cites this paper
• Models of repair mechanisms for future treatment modalities of Parkinson's disease.

  2002cites this paper
• Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin.

  2002cites this paper
• Evaluation of the protective effect of oestradiol against toxicity induced by 6‐hydroxydopamine and 1‐methyl‐4‐phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture

  2002influential citation
• Stimulation of the regrowth of MPP+-damaged dopaminergic fibers by the treatment of mesencephalic cultures with basigin

  2001cites this paper
• Prospects for the treatment of Parkinson’s disease using neurotrophic factors

  2001cites this paper
• Effects of basic fibroblast growth factor on central nervous system functions.

  2001cites this paper
• The Role of Neurotrophic Factors in Psychostimulant-induced Behavioral and Neuronal Plasticity

  2001cites this paper
• Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat

  2000cites this paper
• S100 IMMUNOREACTIVITY IS INCREASED IN REACTIVE ASTROCYTES OF THE VISUAL PATHWAYS FOLLOWING A MECHANICAL LESION OF THE RAT OCCIPITAL CORTEX

  2000cites this paper
• Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine.

  2000cites this paper
• What role(s) for TGFalpha in the central nervous system?

  2000cites this paper
• Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity.

  2000cites this paper
• Further Evidence for the Involvement of Epidermal Growth Factor in the Signaling Pathway of Vitamin B12 (Cobalamin) in the Rat Central Nervous System

  2000cites this paper
• Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease.

  2000cites this paper
• What role(s) for TGFα in the central nervous system

  2000cites this paper
• Molecules for Neuroprotection and Regeneration in Animal Models of Parkinson’s Disease

  2000cites this paper
• Neurotrophic effects of simplified mastigophorene analogs on mesencephalic dopaminergic cells in primary culture

  2000cites this paper
• Central Nervous System Diseases

  2000influential citation
• Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro

  1999cites this paper
• Brain Damage in Preterm Newborns: Might Enhancement of Developmentally Regulated Endogenous Protection Open a Door for Prevention?

  1999cites this paper
• Glial Cells Mediate Toxicity in Glutathione‐Depleted Mesencephalic Cultures

  1999cites this paper
• Cellular aspects of trophic actions in the nervous system.

  1999cites this paper
• Regulation of dopamine uptake by basic fibroblast growth factor and epidermal growth factor in cultured rat astrocytes.

  1999cites this paper
• Therapeutic Potential of Nerve Growth Factors in Parkinson’s Disease

  1999cites this paper
• Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Hippocampus: Modulation of Expression by Seizures and Anti-Excitotoxic Action

  1999cites this paper
• Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.

  1998cites this paper
• [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.

  1998cites this paper
• Sonic Hedgehog Protein

  1998cites this paper
• Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats

  1998cites this paper
• Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease.

  1998cites this paper
• Somatic Gene Transfer and Cell Transplantation Strategies for Neurodegenerative Diseases

  1998cites this paper
• The growth-promoting action of the insulin-like growth factor family in the magnocellular neurosecretory system during axonal sprouting

  1998cites this paper
• L1 neural cell adhesion molecule is a survival factor for fetal dopaminergic neurons

  1998cites this paper
• Basic Fibroblast Growth Factor Stimulation of Glial Cells Protects Dopamine Neurons from 6‐Hydroxydopamine Toxicity: Involvement of the Glutathione System

  1997cites this paper
• Effects of fibroblast growth factors on MPTP-induced parkinsonian syndrome in mice

  1997cites this paper
• The neurotrophic action and signalling of epidermal growth factor.

  1997cites this paper
• Rescue of Mesencephalic Dopamine Neurons by Anticancer Drug Cytosine Arabinoside

  1997cites this paper
• Role of Protein Kinase C in Microglia‐induced Neurotoxicity in Mesencephalic Cultures

  1997cites this paper
• Growth factors rescue embryonic dopamine neurons from programmed cell death.

  1996cites this paper
• Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.

  1996cites this paper
• Basic fibroblast growth factor treatment partially protects from visual deficits but does not increase retinal ganglion cell survival following controlled optic nerve crush

  1996cites this paper
• Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat.

  1996cites this paper
• Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro.

  1996cites this paper
• Neuroprotection and Neurotransplantation Strategies in Models of Parkinson’s Disease

  1996cites this paper
• Neurotrophic factors: Towards a restorative therapy of Parkinson's disease

  1996cites this paper
• Neurotherapeutics

  1996cites this paper
• Glial Cell Line‐Derived Neurotrophic Factor Exerts Neurotrophic Effects on Dopaminergic Neurons In Vitro and Promotes Their Survival and Regrowth After Damage by 1‐Methyl‐4‐Phenylpyridinium

  1996cites this paper
• Therapeutic Use of Neurotrophic Factors

  1995cites this paper
• Epidermal Growth Factor and Basic Fibroblast Growth Factor Protect Dopaminergic Neurons from Glutamate Toxicity in Culture

  1995cites this paper
• Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures.

  1995cites this paper
• Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro

  1995cites this paper
• Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments.

  1995cites this paper
• GDNF reduces apoptosis in dopaminergic neurons in vitro

  1995cites this paper
• Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.

  1995cites this paper
• Basic Fibroblast Growth Factor Protects against Excitotoxicity and Chemical Hypoxia in Both Neonatal and Adult Rats

  1995cites this paper
• The Alzheimer Amyloid Precursor Proteoglycan (Appican) Is Present in Brain and Is Produced by Astrocytes but Not by Neurons in Primary Neural Cultures (*)

  1995cites this paper
• Expression of EGF receptor mRNA in rat nigrostriatal system

  1994cites this paper